This study shows that fully closed-loop insulin delivery can potentially provide health-care professionals with an effective and safe clinical tool to manage hyperglycaemia in patients receiving parenteral or enteral nutritional support in hospital. This evidence concerns the gene INS and Hyperglycemia.